Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: István Puskás

research chemist
January 3, 2024 Analysis / Non-pharma applications

Reinforced double-threaded slide-ring networks for accelerated hydrogel discovery and 3D printing

Stretchable slide-ring hydrogels are typically soft because of an elasticity-toughness trade-off. Herein, Ke et al. have developed crystalline-domain-reinforced double-threaded slide-ring

Continue reading

December 18, 2023 CD as API / Pharma applications / Uncategorized

HPBCD was tested as a possible therapeutic agent in Amyotrophic Lateral Sclerosis (ALS) model

Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), is a rare and terminal neurodegenerative disease that results

Continue reading

December 4, 2023 Food / Life sciences / Non-pharma applications

Geographical variation of gut microflora shows diversity in catabolizing alpha-cyclodextrin

A recent study published by Bhagat et al. [1] aimed to investigate the functions of gut microbiota in broiler chickens

Continue reading

food presentation on ceramic plate
November 21, 2023 Food / Life sciences

Wasabi’s bioactive component 6-MSITC formulated with alfa-cyclodextrin improved memory proven in clinical trial.

6-(Methylsulfinyl)hexyl isothiocyanate (6-MSITC ) is the main bioactive compound of wasabi. A Japanese panel of scientists investigated the benefits of

Continue reading

Lungs, anatomy hand drawn illustration
October 31, 2023 Drug delivery / Pharma applications

Beta-cyclodextrin containing theophylline formulation of rapid, but also prolonged adsorption profile: exploiting interaction characterized with Bs type of isotherm

Modi Mundi Pharma Pvt Ltd., India has developed a beta-cyclodextrin containing oral dosage form of 400 mg theophylline marketed under

Continue reading

October 30, 2023 Life sciences

Cyclodextrin enabled transdermal peptide delivery by cyclodextrin

Non invasive peptide delivery is a highly needed, especially challenging discipline. Auro Wellness has developed a transdermally absorbed glutathione (GSH)

Continue reading

October 26, 2023 CD derivatives / Cosmetics and toilettry / Non-pharma applications

HPBCD in pet care: shampoo and deodorising spray for dogs

The cosmetic use of cyclodextrins has been long discussed in various publications, including a slidedeck authored by Cyclolab researchers: https://cyclolab.hu/userfiles/Cyclodextrins%20in%20cosmetics.pdf

Continue reading

October 2, 2023 Life sciences / Pharma applications

Cyclodextrin related patent application of 2023 Nobel laureate Katalin Karikó

This year’s Nobel Prize in physiology or medicine has been awarded to Katalin Karikó and Drew Weissman for their work

Continue reading

September 21, 2023 CD as API / CD derivatives / Pharma applications / Uncategorized

Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment

Cyclodextrins (CDs), the therapeutic candidates for Niemann–Pick disease type C (NPC), function dually as a shuttle and sink that catalytically

Continue reading

September 18, 2023 CD derivatives / Drug delivery / Pharma applications

Novel medicament comprising fosaprepitant/SBECD has been approved.

Fosaprepitant has been initially approved in 2008 in the USA. In August, 2023, an improved composition also containing SBECD has

Continue reading

Posts pagination

«Previous Posts 1 … 8 9 10 11 12 … 21 Next Posts»

Recent Posts

  • Special Issue “Cyclodextrin-Functionalized Materials for Drug Delivery, Pharmaceutical and Medical Applications”
  • Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle
  • Cyclodextrin-based electrochemical sensors for PFAS detection
  • FDA: Inclusion complex of a GRAS guest and a GRAS host is also GRAS
  • HPBCD for the treatment of irreversible white matter injury

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (72)
  • CD as API (350)
  • CD derivatives (422)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (803)
  • E-ducation (63)
  • Environmental (140)
  • Events (236)
  • Food (229)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (408)
  • Other industrial use (110)
  • Pharma applications (1,200)
  • Supramolecular systems (44)
  • Uncategorized (161)

Top Posts

  • Special Issue "Cyclodextrin-Functionalized Materials for Drug Delivery, Pharmaceutical and Medical Applications"
  • Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • 4th International Biotechnology Congress 2020
  • Cholesteryl Cyclodextrin for Enhanced Delivery of Doxorubicin and 5-Fluorouracil
  • Call for Book Chapters: Cyclodextrin Systems for Green Hydrogen Production
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • FDA: Inclusion complex of a GRAS guest and a GRAS host is also GRAS
  • Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment
  • Nystatin:β-cyclodextrin inclusion complexes - revisited

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,475 other subscribers

Loading Comments...